Selection of resistance of telithromycin against Haemophilus influenzae, Moraxella catarrhalis and streptococci in comparison with macrolides

Journal of Antimicrobial Chemotherapy

Volumn 54, Issue 2, 2004, Pages 542-545

  Drago, Lorenzo ^a   De Vecchi, Elena ^a   Nicola, Lucia ^a   Colombo, Alberto ^a   Gismondo, Maria Rita ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Azithromycin; Clarithromycin; In vitro selection of resistance; Ketolides; Respiratory pathogens

Indexed keywords

AZITHROMYCIN; CLARITHROMYCIN; MACROLIDE; TELITHROMYCIN;

ANALYTIC METHOD; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; HAEMOPHILUS INFLUENZAE; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MORAXELLA CATARRHALIS; NONHUMAN; SPECIES DIFFERENCE; SPECIES DIVERSITY; STREPTOCOCCUS;

ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CLARITHROMYCIN; DRUG RESISTANCE, BACTERIAL; GENE FREQUENCY; HAEMOPHILUS INFLUENZAE; HUMANS; KETOLIDES; MACROLIDES; MICROBIAL SENSITIVITY TESTS; MORAXELLA (BRANHAMELLA) CATARRHALIS; MUTATION; RESPIRATORY TRACT INFECTIONS; STREPTOCOCCUS; STREPTOCOCCUS PNEUMONIAE;

EID: 4444241452     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkh339     Document Type: Article

References (10)

1. Baquero, F. (1999). Evolving resistance patterns of Streptococcus pneumoniae: a link with long-acting macrolide consumption? Journal of Chemotherapy 11, 35-43.
2. Ackermann, G. & Rodloff, A. C. (2003). Drugs of the 21st century: telithromycin (HMR 3647) - the first ketolide. Journal of Antimicrobial Chemotherapy 51, 497-511.
3. B resistance phenotype. Journal of Antimicrobial Chemotherapy 40, 85-90.
4. National Committee for Clinical Laboratory Standards. (2003). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically - Sixth Edition: Approved Standard M07-A6. NCCLS, Villanova, PA, USA.
5. Buxbaum, A., Forsthuber, S., Graninger, W. et al. (2003). Comparative activity of telithromycin against typical community acquired-respiratory pathogens. Journal of Antimicrobial Chemotherapy 52,371-4.
6. Michéa Hamzehpour, M., Kahr, A., Pechère, J. C. et al. (1994). In vitro stepwise selection of resistance to quinolones, β-lactams and amikacin in nosocomial Gram-negative bacilli. Infection 22, Suppl. 2, S105-10.
7. Davies, T. A., Dewasse, B. E., Jacobs, M. R. et al. (2000). In vitro development of resistance to telithromycin (HMR 3647), four macrolides, clindamycin, and prystinamycin in Streptococcus pneumoniae. Antimicrobial Agents and Chemotherapy 44, 414-7.
8. Clark, C., Bozdogan, B., Peric, M. et aL (2002). In vitro selection of resistance in Haemophilus influenzae by amoxicillin-clavulanate, cefpodoxime, cefprozil, azithromycin, and clarithromycin. Antimicrobial Agents and Chemotherapy 46, 2956-62.
9. Liu, M. & Douthwaite, S. (2002). Activity of the ketolide telithromycin is refractory to Erm monomethylation of bacterial rRNA. Antimicrobial Agents and Chemotherapy 46, 1629-33.
10. Tait-Kamradt, A., Davies, T., Cronan, M. et al. (2000). Mutations in 23S rRNA and ribosomal protein L4 account for resistance in pneumococcal strains selected in vitro by macrolide passage. Antimicrobial Agents and Chemotherapy 44, 2118-25.